Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
36.60    0.10 (0.27%)
Bid:
36.50
Ask:
36.70
Spread: 0.20 (0.548%)
Market Cap: £26.87m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

AGM Trading Update

2 Sep 2021 07:00

RNS Number : 4620K
Carclo plc
02 September 2021
 

 

2 September 2021

 

Carclo plc

 

("Carclo" or the "Group")

 

AGM Trading Update

 

 

Carclo, a global manufacturer, principally of fine tolerance injection moulded plastic parts, publishes the following trading update for the first four months of its financial year ending 31 March 2022 ("FY22"), ahead of its Annual General Meeting which takes place today.

 

The Group has made an encouraging start to FY22, maintaining the momentum built in the second half of the prior year in spite of a challenging operating environment. As a result, Group trading was ahead of management's expectations for the first four months of FY22, with performance also ahead of the equivalent prior period.

 

The Carclo Technical Plastics (CTP) division has performed strongly despite operational headwinds. Specifically, labour availability in the division's US businesses has been challenging in the early part of FY22, although this is expected to improve in the coming months as government support packages come to an end. The availability and pricing of raw materials has also been difficult in recent months as general supply and logistics issues impact the business. Some of the resultant input cost inflation has been offset by sales price increases. Inventories have also been held at a higher level to protect against supply disruption.

 

Alongside the positive trading performance, the division continues to make good commercial progress with order intake in the medical and diagnostic sector remaining strong and showing some good potential.

 

The new customer programmes announced in December 2020 are moving into production on time and to budget, with these providing significant growth potential from the latter part of FY22.

 

The Aerospace division has experienced early signs of market recovery with order intake exceeding sales for the first four months of FY22 following a FY21 where sales exceeded order intake. In addition to a general market improvement, the division has been successful in winning business with new customers in line with its long-term strategy.

 

Cash generation has also continued to be good in the first four months of FY22 and ahead of the prior year, with net debt as at 31 July 2021 of £28.4m and net debt excluding lease liabilities of £21.8m. At a Group level the positive developments previously reported relating to the relationships with our principal bank and pension trustees have been maintained and further initiatives are being developed with the pension trustees to aim to improve the pension scheme's funding level more quickly than would be the case by employer contributions alone.

Carclo plans to announce its interim results for the six months to 30 September 2021 in November 2021.

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a global provider of value-adding engineered solutions for the medical, optical and aerospace industries.

 

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc 01924 268040

Nick Sanders - Executive Chairman

 

FTI Consulting 020 3727 1340

Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUWGBUPGGMG
Date   Source Headline
29th Apr 20264:59 pmRNSDirector Dealing – Late Notification
27th Apr 20267:00 amRNSHolding(s) in Company
23rd Apr 202610:34 amRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Update
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
24th Dec 202510:10 amRNSDirector/PDMR Shareholding
25th Nov 20257:00 amRNSDirector/PDMR Shareholding
21st Nov 20257:00 amRNSHalf-year Financial Report
17th Nov 20257:00 amRNSNotice of Half Year Results
30th Sep 20256:20 pmRNSDirector/PDMR Shareholding
30th Sep 20256:14 pmRNSDirector/PDMR Shareholding
26th Sep 202512:30 pmRNSResult of AGM
26th Sep 20257:00 amRNSTrading Update
19th Sep 20255:58 pmRNSDirector/PDMR Shareholding
17th Sep 20257:00 amRNSChange of Auditor
11th Sep 20258:41 amRNSDirector/PDMR Shareholding
1st Sep 20257:30 amRNSRestoration - Carclo PLC
29th Aug 202511:55 amRNSNotice of AGM
29th Aug 20257:00 amRNSFull Year 2025 audited results
28th Aug 20257:00 amRNSNotice of Results and Investor Presentation
1st Aug 20257:30 amRNSSuspension - Carclo PLC
17th Jul 20254:42 pmRNSHolding(s) in Company
15th Jul 20257:00 amRNSContract renewal strengthens revenue visibility
10th Jul 20257:00 amRNSTrading Statement & Delay in 2025 Audited Results
2nd May 202511:33 amRNSHolding(s) in Company
30th Apr 20257:00 amRNSTrading Statement
28th Apr 20255:06 pmRNSHolding(s) in Company
24th Apr 20254:02 pmRNSRefinancing Arrangements, Pension Scheme Valuation
3rd Apr 20257:00 amRNSHolding(s) in Company
6th Mar 202510:43 amRNSHolding(s) in Company
18th Feb 20255:10 pmRNSHolding(s) in Company
13th Feb 20257:00 amRNSCFO Appointment
19th Dec 20243:49 pmRNSHolding(s) in Company
5th Dec 20247:00 amRNSInterim Report and Accounts 30 September 2024
12th Nov 202411:11 amRNSNotice of Interim Results & Investor Presentation
10th Sep 20249:33 amRNSHolding(s) in Company
5th Sep 20241:30 pmRNSResult of AGM
5th Sep 20247:00 amRNSTrading Update
16th Aug 202412:32 pmRNSHolding(s) in Company
5th Aug 202412:11 pmRNSHolding(s) in Company
31st Jul 202410:00 amRNS2024 Annual Report & Accounts and Notice of AGM
30th Jul 20243:21 pmRNSHolding(s) in Company
24th Jul 20242:49 pmRNSHolding(s) in Company
24th Jul 202412:57 pmRNSHolding(s) in Company
23rd Jul 20243:48 pmRNSHolding(s) in Company
23rd Jul 20241:08 pmRNSDirector/PDMR Shareholding
18th Jul 20247:00 amRNSFinal Results
17th Jul 20241:07 pmRNSHolding(s) in Company
16th Jul 20247:00 amRNSNotice of Results
8th Jul 20248:51 amRNSBank Facilities Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.